$AONC
American Oncology Network, Inc. Stock $aonc

$aonc Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000183999824000040 Filed on May 15, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$364.3M	$0.00
YoY Change
Cost Of Revenue	$354.9M	$278.5M
YoY Change	27.43%
Gross Profit	$9.391M	-$278.5M
YoY Change	-103.37%
Gross Profit Margin	2.58%
Selling, General & Admin	$28.28M
YoY Change
% of Gross Profit	301.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.506M	$2.207M
YoY Change	13.55%
% of Gross Profit	26.69%
Operating Expenses	$28.28M	$1.014M
YoY Change	2688.69%	305.11%
Operating Profit	-$19.24M	-$1.014M
YoY Change	1797.27%	305.11%
Interest Expense	$1.763M	$2.205M
YoY Change	-20.03%	26687.48%
% of Operating Profit
Other Income/Expense, Net	-$1.908M	$1.646M
YoY Change	-215.93%	-56.37%
Pretax Income	-$22.12M	$631.9K
YoY Change	-3600.06%	-82.06%
Income Tax	$2.900M	$452.5K
% Of Pretax Income		71.61%
Net Earnings	-$7.799M	$179.4K
YoY Change	-4447.07%	-94.91%
Net Earnings / Revenue	-2.14%
Basic Earnings Per Share	-$1.22	$0.00
Diluted Earnings Per Share	-$1.22	$0.02
COMMON SHARES
Basic Shares Outstanding	7.528M shares	10.11M
Diluted Shares Outstanding	7.528M shares	0.000 shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$105.0M	$3.980K
YoY Change	2639322.11%	-99.32%
Cash & Equivalents	$74.94M	$3.975K
Short-Term Investments	$30.11M
Other Short-Term Assets	$5.029M	$169.9K
YoY Change	2860.15%	-65.24%
Inventory	$44.29M
Prepaid Expenses		$169.9K
Receivables	$132.3M
Other Receivables	$34.80M
Total Short-Term Assets	$324.0M	$173.9K
YoY Change	186230.2%	-83.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$84.36M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$19.04M
YoY Change		-94.29%
Other Assets	$12.22M	$0.00
YoY Change
Total Long-Term Assets	$97.96M	$19.04M
YoY Change	414.58%	-94.29%
TOTAL ASSETS
Total Short-Term Assets	$324.0M	$173.9K
Total Long-Term Assets	$97.96M	$19.04M
Total Assets	$421.9M	$19.21M
YoY Change	2096.32%	-94.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$188.3M	$3.730M
YoY Change	4949.21%	276.8%
Accrued Expenses	$34.92M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$150.0K
YoY Change	-100.0%
Long-Term Debt Due	$1.205M
YoY Change
Total Short-Term Liabilities	$233.8M	$7.141M
YoY Change	3174.24%	621.45%
LONG-TERM LIABILITIES
Long-Term Debt	$80.86M	$0.00
YoY Change
Other Long-Term Liabilities	$11.34M	$13.11M
YoY Change	-13.46%	-24.95%
Total Long-Term Liabilities	$92.20M	$13.11M
YoY Change	603.46%	-24.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$233.8M	$7.141M
Total Long-Term Liabilities	$92.20M	$13.11M
Total Liabilities	$365.8M	$20.25M
YoY Change	1706.68%	9.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$175.6M	-$19.66M
YoY Change	793.2%	13.26%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$167.4M	-$19.66M
YoY Change
Total Liabilities & Shareholders Equity	$421.9M	$19.21M
YoY Change	2096.32%	-94.26%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$7.799M	$179.4K
YoY Change	-4447.07%	-94.91%
Depreciation, Depletion And Amortization	$2.506M	$2.207M
YoY Change	13.55%
Cash From Operating Activities	$45.14M	-$1.000M
YoY Change	-4611.99%	350.13%
INVESTING ACTIVITIES
Capital Expenditures	$4.132M	$2.777M
YoY Change	48.79%
Acquisitions
YoY Change
Other Investing Activities	$5.654M	$321.6M
YoY Change	-98.24%
Cash From Investing Activities	$1.522M	$321.6M
YoY Change	-99.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$254.0K	-321.0M
YoY Change	-99.92%
NET CHANGE
Cash From Operating Activities	$45.14M	-1.000M
Cash From Investing Activities	$1.522M	321.6M
Cash From Financing Activities	-$254.0K	-321.0M
Net Change In Cash	$46.41M	-370.3K
YoY Change	-12630.75%	66.63%
FREE CASH FLOW
Cash From Operating Activities	$45.14M	-$1.000M
Capital Expenditures	$4.132M	$2.777M
Free Cash Flow	$41.01M	-$3.777M
YoY Change	-1185.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7588000	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1230000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2894000	usd
CY2023Q4	us-gaap	Assets Assets	374453000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	127645000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11410000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	22327000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	971000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6692000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	169045000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	80641000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	39803000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14251000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	303740000	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	64986000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	364339000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	354948000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	278534000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23717000	usd
CY2023Q1	us-gaap	Members Equity MembersEquity	60594000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2024Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2024Q1	aonc	Stockholders Equity Number Of Days After The Redemption Notice Date For Redemption To Be Settled StockholdersEquityNumberOfDaysAfterTheRedemptionNoticeDateForRedemptionToBeSettled	P10D
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12216000	usd
CY2024Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1230000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2024Q1	us-gaap	Assets Assets	421921000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	188329000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12628000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	25186000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	971000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6715000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	64986000	usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	157716000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	167025000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8164000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	31170	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	14729	shares
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	97000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	0	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	77000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	81000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-175594000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-161812000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-167446000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-161727000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	852000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	429000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-166594000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-161298000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	421921000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	374453000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	303731000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	28277000	usd
CY2024Q1	aonc	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	352000	usd
CY2023Q1	aonc	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	1971000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	383577000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	304222000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-19238000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-491000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1763000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1417000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	793000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	57000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1908000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	466000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-22116000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1385000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2894000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	aonc	Income Loss From Continuing Operations Before Equity Method Investments Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNetOfTax	-25010000	usd
CY2023Q1	aonc	Income Loss From Continuing Operations Before Equity Method Investments Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNetOfTax	-1385000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	49000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-101000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-24961000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1486000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	43000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	0	usd
CY2024Q1	aonc	Net Income Loss Including Portion Attributable To Redeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToRedeemableNoncontrollingInterest	-25004000	usd
CY2023Q1	aonc	Net Income Loss Including Portion Attributable To Redeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToRedeemableNoncontrollingInterest	-1486000	usd
CY2024Q1	aonc	Net Income Loss Including Portion Attributable To Noncontrolling Interest Before Recapitalization NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalization	0	usd
CY2023Q1	aonc	Net Income Loss Including Portion Attributable To Noncontrolling Interest Before Recapitalization NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalization	-1486000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-17163000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7841000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7841000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	0	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	0	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.22
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.22
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7527882	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7527882	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	0	shares
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-22000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	64000	usd
CY2024Q1	aonc	Other Comprehensive Income Loss Net Of Tax Including Redeemable Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxIncludingRedeemableNoncontrollingInterest	-22000	usd
CY2023Q1	aonc	Other Comprehensive Income Loss Net Of Tax Including Redeemable Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxIncludingRedeemableNoncontrollingInterest	64000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-25026000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1422000	usd
CY2024Q1	aonc	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Before Recapitalization ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalization	0	usd
CY2023Q1	aonc	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Before Recapitalization ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalization	-1422000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-17180000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
CY2024Q1	aonc	Comprehensive Income Loss Net Of Tax Attributable To Common Stockholders ComprehensiveIncomeLossNetOfTaxAttributableToCommonStockholders	-7846000	usd
CY2023Q1	aonc	Comprehensive Income Loss Net Of Tax Attributable To Common Stockholders ComprehensiveIncomeLossNetOfTaxAttributableToCommonStockholders	0	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	6652000	shares
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	64986000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	167025000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-161298000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-17000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4000	usd
CY2024Q1	aonc	Redeemable Noncontrolling Interest Equity Based Compensation RedeemableNoncontrollingInterestEquityBasedCompensation	399000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9696000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	97000	usd
CY2024Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	380000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-17163000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-7799000	usd
CY2024Q1	aonc	Redeemable Noncontrolling Interest Equity Fair Value Adjustment RedeemableNoncontrollingInterestEquityFairValueAdjustment	15636000	usd
CY2024Q1	aonc	Adjustments To Additional Paid In Capital Fair Value Adjustment Redeemable Noncontrolling Interest AdjustmentsToAdditionalPaidInCapitalFairValueAdjustmentRedeemableNoncontrollingInterest	-15636000	usd
CY2024Q1	aonc	Redeemable Noncontrolling Interest Stock Redeemed RedeemableNoncontrollingInterestStockRedeemed	8164000	usd
CY2024Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-8164000	usd
CY2024Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	6652000	shares
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	64986000	usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	157716000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-166594000	usd
CY2022Q4	us-gaap	Members Equity MembersEquity	62016000	usd
CY2023Q1	aonc	Net Income Loss Including Portion Attributable To Noncontrolling Interest Before Recapitalization NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalization	-1486000	usd
CY2023Q1	aonc	Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Before Recapitalization OtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalization	-64000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-24961000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1486000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2506000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2207000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	215000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	176000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	2894000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2040000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2224000	usd
CY2024Q1	aonc	Gain Loss On Warrant And Derivative Net GainLossOnWarrantAndDerivativeNet	1611000	usd
CY2023Q1	aonc	Gain Loss On Warrant And Derivative Net GainLossOnWarrantAndDerivativeNet	0	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10094000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	49000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-101000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-393000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3149000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16711000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-281000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4854000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	752000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	342000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	525000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-3442000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4579000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2826000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	61675000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5316000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1218000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2757000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	4241000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-296000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2042000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1777000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2752000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2032000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	45137000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-329000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4132000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2777000	usd
CY2024Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	7069000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1442000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	12624000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1423000	usd
CY2024Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	99000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	153000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1522000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2643000	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	157000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	105000	usd
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	97000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-254000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-105000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	46405000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3077000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28539000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26926000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74944000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23849000	usd
CY2024Q1	us-gaap	Notes Issued1 NotesIssued1	1420000	usd
CY2023Q1	us-gaap	Notes Issued1 NotesIssued1	0	usd
CY2024Q1	aonc	Noncash Contributions From Noncontrolling Interest NoncashContributionsFromNoncontrollingInterest	-380000	usd
CY2023Q1	aonc	Noncash Contributions From Noncontrolling Interest NoncashContributionsFromNoncontrollingInterest	0	usd
CY2024Q1	aonc	Lease Right Of Use Asset And Liability Reduction From Lease Terminations LeaseRightOfUseAssetAndLiabilityReductionFromLeaseTerminations	0	usd
CY2023Q1	aonc	Lease Right Of Use Asset And Liability Reduction From Lease Terminations LeaseRightOfUseAssetAndLiabilityReductionFromLeaseTerminations	-1023000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1055000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2024Q1	aonc	Number Of Oncology Practices NumberOfOncologyPractices	32	practice
CY2024Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	19	state
CY2024Q1	aonc	Recapitalization Exchange Ratio Units RecapitalizationExchangeRatioUnits	2524000	shares
CY2024Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-7800000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-17200000	usd
CY2023Q1	aonc	Net Income Loss Including Portion Attributable To Noncontrolling Interest Before Recapitalization NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalization	-1500000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;padding-left:31.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Estimates and Assumptions </span></div><div style="margin-top:10pt;padding-left:31.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	14729	shares
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	100000	usd
CY2024Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	16441	shares
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	100000	usd
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	31170	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2024Q1	aonc	Reverse Recapitalization Equity Conversion Ratio ReverseRecapitalizationEquityConversionRatio	1
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q3	aonc	Cash And Cash Equivalents Acquired Through Reverse Recapitalization CashAndCashEquivalentsAcquiredThroughReverseRecapitalization	1493000	usd
CY2023Q3	aonc	Current Liabilities Assumed In Reverse Recapitalization CurrentLiabilitiesAssumedInReverseRecapitalization	13295000	usd
CY2023Q3	aonc	Noncurrent Liabilities Assumed In Reverse Recapitalization NoncurrentLiabilitiesAssumedInReverseRecapitalization	6791000	usd
CY2023Q3	aonc	Reverse Recapitalization Net ReverseRecapitalizationNet	-18593000	usd
CY2024Q1	aonc	Gain Loss On Reverse Recapitalization GainLossOnReverseRecapitalization	18200000	usd
CY2023Q3	aonc	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	13000000	usd
CY2024Q1	aonc	Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost	105194000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	377000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	7000	usd
CY2024Q1	aonc	Cash Cash Equivalents And Available For Sale Debt Securities CashCashEquivalentsAndAvailableForSaleDebtSecurities	105564000	usd
CY2023Q4	aonc	Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost	64312000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	402000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	9000	usd
CY2023Q4	aonc	Cash Cash Equivalents And Available For Sale Debt Securities CashCashEquivalentsAndAvailableForSaleDebtSecurities	64705000	usd
CY2024Q1	aonc	Rebates Receivable Current RebatesReceivableCurrent	34112000	usd
CY2023Q4	aonc	Rebates Receivable Current RebatesReceivableCurrent	33708000	usd
CY2024Q1	aonc	Other Miscellaneous Receivables Net Current OtherMiscellaneousReceivablesNetCurrent	687000	usd
CY2023Q4	aonc	Other Miscellaneous Receivables Net Current OtherMiscellaneousReceivablesNetCurrent	566000	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	34799000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	34274000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	44288000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	44569000	usd
CY2024Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	67804000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	65074000	usd
CY2024Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	26807000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	24635000	usd
CY2024Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	40997000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	40439000	usd
CY2024Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	12879000	usd
CY2023Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	15078000	usd
CY2024Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4913000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	2700000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	2700000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1205000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1189000	usd
CY2024Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	3489000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	3360000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	25186000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	22327000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	81250000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	81250000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	394000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	609000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	80856000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	80641000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.131
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2900000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43358000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43349000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5513000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5794000	usd
CY2024Q1	aonc	Lease Right Of Use Asset LeaseRightOfUseAsset	48871000	usd
CY2023Q4	aonc	Lease Right Of Use Asset LeaseRightOfUseAsset	49143000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6715000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6692000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1205000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1189000	usd
CY2024Q1	aonc	Finance And Operating Lease Liability Current FinanceAndOperatingLeaseLiabilityCurrent	7920000	usd
CY2023Q4	aonc	Finance And Operating Lease Liability Current FinanceAndOperatingLeaseLiabilityCurrent	7881000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	39786000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	39803000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4239000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4548000	usd
CY2024Q1	aonc	Lease Liability LeaseLiability	51945000	usd
CY2023Q4	aonc	Lease Liability LeaseLiability	52232000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2795000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2870000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	281000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	110000	usd
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	86000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	17000	usd
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	586000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	578000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	3748000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	3575000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	6959000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	1132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10014000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1487000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9620000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1249000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8370000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1185000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6271000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	948000	usd
CY2024Q1	aonc	Lessee Operating Lease Liability To Be Paid Due After Year Four LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour	19147000	usd
CY2024Q1	aonc	Finance Lease Liability To Be Paid Due After Year Four FinanceLeaseLiabilityToBePaidDueAfterYearFour	261000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	60381000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	6262000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13880000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	818000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	46501000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	5444000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6715000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1205000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	39786000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4239000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y6M14D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y11M4D
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P6Y10M2D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M3D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0633
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0664
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0671
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0630
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2799000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2845000	usd
CY2024Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	86000	usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	17000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	291000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	105000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2048000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4326000	usd
CY2024Q1	aonc	Financing Receivable Amortization Period FinancingReceivableAmortizationPeriod	P60M
CY2024Q1	aonc	Financing Receivable Borrowing Rate FinancingReceivableBorrowingRate	0.0709
CY2023Q4	aonc	Financing Receivable Borrowing Rate FinancingReceivableBorrowingRate	0.0718
CY2024Q1	us-gaap	Notes Receivable Net NotesReceivableNet	2655000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	2754000	usd
CY2024Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	2498000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1604000	usd
CY2024Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	157000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1150000	usd
CY2024Q1	us-gaap	Members Capital MembersCapital	65000000	usd
CY2024Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.08
CY2024Q1	us-gaap	Members Capital MembersCapital	65000000	usd
CY2024Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.08
CY2024Q1	us-gaap	Members Capital MembersCapital	65000000	usd
CY2024Q1	aonc	Stockholders Equity Conversion Period StockholdersEquityConversionPeriod	P5Y
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7841000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7841000	usd
CY2024Q1	us-gaap	Undistributed Earnings UndistributedEarnings	-9201180	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7527882	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.22
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.22
CY2024Q1	aonc	Stockholders Equity Redemption Ratio StockholdersEquityRedemptionRatio	1
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Redemption Value RedeemableNoncontrollingInterestEquityRedemptionValue	157700000	usd
CY2024Q1	aonc	Redeemable Noncontrolling Interest Equity Excess Over Carrying Amount RedeemableNoncontrollingInterestEquityExcessOverCarryingAmount	15600000	usd

Files In Submission

Name	View Source	Status
0001839998-24-000040-index-headers.html	Edgar Link	pending
0001839998-24-000040-index.html	Edgar Link	pending
0001839998-24-000040.txt	Edgar Link	pending
0001839998-24-000040-xbrl.zip	Edgar Link	pending
aonc-20240331.htm	Edgar Link	pending
aonc-20240331.xsd	Edgar Link	pending
aonc-302certceoexhibit3111.htm	Edgar Link	pending
aonc-302certcfoexhibit3121.htm	Edgar Link	pending
aonc-906certceoexhibit3211.htm	Edgar Link	pending
aonc-906certcfoexhibit3221.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
aonc-20240331_def.xml	Edgar Link	unprocessable
aonc-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
aonc-20240331_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aonc-20240331_cal.xml	Edgar Link	unprocessable
aonc-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AONC
American Oncology Network, Inc. Stock $aonc

2024 Q1 Form 10-Q Financial Statement

#000183999824000040 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AONC American Oncology Network, Inc. Stock $aonc

2024 Q1 Form 10-Q Financial Statement

#000183999824000040 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AONC
American Oncology Network, Inc. Stock $aonc